Needham Reiterates Buy on Cardlytics, Maintains $12 Price Target
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Kyle Peterson has reiterated a Buy rating on Cardlytics (NASDAQ:CDLX) and maintained a $12 price target.
June 11, 2024 | 9:28 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Needham analyst Kyle Peterson has reiterated a Buy rating on Cardlytics and maintained a $12 price target, indicating continued confidence in the company's performance.
The reiteration of a Buy rating and the maintenance of a $12 price target by a reputable analyst suggests a positive outlook for Cardlytics. This could lead to increased investor confidence and potentially a short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100